Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul 27;24(1):463.
doi: 10.1186/s13054-020-03177-x.

Inhibiting IL-6 in COVID-19: we are not sure

Affiliations
Comment

Inhibiting IL-6 in COVID-19: we are not sure

Patrick M Honore et al. Crit Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare to have no competing interests.

Comment on

References

    1. Convertino I, Tuccori M, Ferraro S, et al. Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients. Crit Care. 2020;24(1):331. doi: 10.1186/s13054-020-03020-3. - DOI - PMC - PubMed
    1. Magro G. SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the ‘culprit lesion’ of ARDS onset? What is there besides tocilizumab? SGP130Fc. Cytokine: X. 2020;2(2):100029. doi: 10.1016/j.cytox.2020.100029. - DOI - PMC - PubMed
    1. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813(5):878–888. doi: 10.1016/j.bbamcr.2011.01.034. - DOI - PubMed
    1. Jones SA, Scheller J, Rose-John S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest. 2011;121(9):3375–3383. doi: 10.1172/JCI57158. - DOI - PMC - PubMed
    1. Wolf J, Rose-John S, Garbers C. Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine. 2014;70(1):11–20. doi: 10.1016/j.cyto.2014.05.024. - DOI - PubMed

LinkOut - more resources